The $38 million factory will receive its ingredients from Indian giant drugmaker Cipla. The director of the factory Emmanuel Katongole, said "Our target is that everybody who requires ARVs will be getting them."
According to official figures, 250,000 AIDS patients require the life-saving medicine, yet each year only an estimated 80,000 can actually afford it.
Health Minister Stephen Malinga told BBC that the country wants to reduce its reliance on expensive imports of vital HIV/Aids and malaria treatments.


